Wednesday, October 21, 2020
Home Latest Pharma-News

Latest Pharma-News

Global partnership to make available 120 million affordable, quality COVID-19 rapid tests

September 28, 2020 : A set of agreements to make available, for low and middle-income countries, affordable, high-quality COVID-19 antigen rapid tests were...

ViiV Healthcare announces start of the CARISEL study for injectable treatment for HIV

September 28, 2020: "ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders...

UK and EU pharma call for medicines to be prioritised in Brexit trade talks

September 28, 2020: "The ABPI and EFPIA have both emphasised the need for trade talks to mitigate medicine supply chain disruptions following...

Oncimmune signs contract with Genentech to profile samples from rheumatology trials

September 2020: "Oncimmune Holdings, the leading global immunodiagnostics group, has announced that it has signed a collaboration with Genentech, a member of...

Novavax launches Phase III trial of Covid-19 vaccine in UK

September 25, 2020: US-based biotechnology firm Novavax has started the first Phase III clinical trial of its potential Covid-19 vaccine, NVX-CoV2373, in...

Monte Rosa Therapeutics Announces $96 Million to develop Protein Degradation molecule

September 24, 2020: "Monte Rosa Therapeutics, a biotechnology company focused on developing precision medicines to degrade disease-causing proteins, announced the closing of...

FDA Approves First Drug to Treat Group of Rare Blood Disorders in Nearly 14 Years

September 25, 2020: "The U.S. Food and Drug Administration approved Nucala (mepolizumab) for adults and children aged 12 years and older with...

Coronavirus (COVID-19) Update: Daily Roundup September 25, 2020

September 25, 2020: "The U.S. Food and Drug Administration (FDA) continued to take action in the ongoing response to the COVID-19 pandemic:

NHS COVID-19 app launches across England and Wales

September 24, 2020: "An NHS COVID-19 contact-tracing app has launched in England and Wales for people over the age of 16.

Coronavirus (COVID-19) Update: Daily Roundup September 24, 2020

September 24, 2020: "The U.S. Food and Drug Administration announced the following actions taken in its ongoing response effort to the COVID-19...

Verona Pharma Initiates late-stage COPD trial programme Initiates

 Sept. 23, 2020: "Verona Pharma, a clinical-stage biopharmaceutical company focused on respiratory diseases, announces the initiation of its ENHANCE (“Ensifentrine as a...

Owlstone Medical’s Breath Biopsy test Improves Detection of Liver Disease

September 22 2020: "Owlstone Medical, the global leader in Breath Biopsy® for applications in early disease detection and precision medicine announced the results of a patient...

Most Read

AZ’s Tagrisso scores priority review from FDA with EGFR-mutated lung cancer

October 20, 2020: "AstraZeneca’s Tagrisso (osimertinib) has received acceptance for its supplemental New Drug Application (sNDA) and has also been granted Priority Review in...

Forxiga recommended for approval in the EU by CHMP for heart failure

October 19, 2020: "AstraZeneca’s Forxiga (dapagliflozin) has been recommended for an indication extension of its marketing authorisation in the European Union (EU) for the...

AstraZeneca advances leadership in renal disease at ASN Kidney Week 2020 Reimagined

October 20, 2020: AstraZeneca will present 84 abstracts, including 12 oral presentations and three late-breaking abstracts, across its industry-leading renal portfolio which...

AbbVie’s VENCLEXTA® Receives FDA Approval for Acute Myeloid Leukemia

October 16, 2020: "AbbVie announced that the U.S. Food and Drug Administration (FDA) has provided full approval to VENCLEXTA® (venetoclax) in combination...